$CLB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CORE LABORATORIES N V.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CORE LABORATORIES N V. Get notifications about new insider transactions in CORE LABORATORIES N V for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2012 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | A | 0.00 | 29,835 | 0 | 29,835 | |
Feb 17 2012 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | A | 0.00 | 12,587 | 0 | 12,587 | |
Feb 17 2012 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | A | 0.00 | 12,587 | 0 | 12,587 | |
Feb 10 2012 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Sell | S | 122.01 | 18 | 2,196 | 34,000 | 34 K to 34 K (-0.05 %) |
Feb 10 2012 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Sell | S | 121.52 | 28,082 | 3,412,398 | 34,018 | 62.1 K to 34 K (-45.22 %) |
Feb 10 2012 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Sell | S | 120.70 | 5,890 | 710,944 | 62,100 | 68 K to 62.1 K (-8.66 %) |
Dec 05 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 400 | 0 | 400 | |
Dec 05 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 117.27 | 106 | 12,431 | 8,645 | 8.8 K to 8.6 K (-1.21 %) |
Dec 05 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 400 | 0 | 8,751 | 8.4 K to 8.8 K (+4.79 %) |
Nov 23 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 9 | 0 | 3,945 | |
Nov 23 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 9 | 0 | 3,936 | |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 110.17 | 1,000 | 110,171 | 181,962 | 183 K to 182 K (-0.55 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 109.24 | 8,810 | 962,374 | 182,962 | 191.8 K to 183 K (-4.59 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 108.51 | 19,974 | 2,167,437 | 191,772 | 211.7 K to 191.8 K (-9.43 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 107.40 | 10,536 | 1,131,532 | 211,746 | 222.3 K to 211.7 K (-4.74 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 106.93 | 2,610 | 279,095 | 222,282 | 224.9 K to 222.3 K (-1.16 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 110.03 | 500 | 55,015 | 224,892 | 225.4 K to 224.9 K (-0.22 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 109.25 | 109,314 | 11,942,259 | 225,392 | 334.7 K to 225.4 K (-32.66 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 108.77 | 18,000 | 1,957,842 | 334,706 | 352.7 K to 334.7 K (-5.10 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 111.17 | 14,826 | 1,648,137 | 352,706 | 367.5 K to 352.7 K (-4.03 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 110.79 | 14,430 | 1,598,643 | 367,532 | 382 K to 367.5 K (-3.78 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Sell | S | 111.22 | 8,700 | 967,593 | 53,468 | 62.2 K to 53.5 K (-13.99 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Sell | S | 110.88 | 1,300 | 144,145 | 62,168 | 63.5 K to 62.2 K (-2.05 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Sell | S | 108.15 | 2,246 | 242,905 | 8,351 | 10.6 K to 8.4 K (-21.19 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | S | 111.63 | 9,352 | 1,043,975 | 180,976 | 190.3 K to 181 K (-4.91 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Sell | S | 112.04 | 6,373 | 714,008 | 51,252 | 57.6 K to 51.3 K (-11.06 %) |
Jul 27 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Sell | S | 111.72 | 43,627 | 4,874,056 | 57,625 | 101.3 K to 57.6 K (-43.09 %) |
Jul 01 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 1,000 | 0 | 4,000 | |
Jul 01 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 111.54 | 265 | 29,558 | 10,597 | 10.9 K to 10.6 K (-2.44 %) |
Jul 01 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 1,000 | 0 | 10,862 | 9.9 K to 10.9 K (+10.14 %) |
Jun 02 2011 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | A | 0.00 | 1,469 | 0 | 1,469 | |
Jun 01 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 10 | 0 | 3,927 | |
May 17 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | M | 0.00 | 1,000 | 0 | 1,000 | |
May 17 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Payment of Exercise | F | 93.22 | 265 | 24,703 | 63,468 | 63.7 K to 63.5 K (-0.42 %) |
May 17 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Buy | M | 0.00 | 1,000 | 0 | 63,733 | 62.7 K to 63.7 K (+1.59 %) |
May 17 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 2,000 | 0 | 2,000 | |
May 17 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Payment of Exercise | F | 93.22 | 529 | 49,313 | 101,252 | 101.8 K to 101.3 K (-0.52 %) |
May 17 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Buy | M | 0.00 | 2,000 | 0 | 101,781 | 99.8 K to 101.8 K (+2.00 %) |
May 17 2011 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 2,000 | |
May 17 2011 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 93.22 | 529 | 49,313 | 190,328 | 190.9 K to 190.3 K (-0.28 %) |
May 17 2011 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 2,000 | 0 | 190,857 | 188.9 K to 190.9 K (+1.06 %) |
Apr 27 2011 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Sell | S | 97.08 | 5,994 | 581,879 | 15,996 | 22 K to 16 K (-27.26 %) |
Apr 27 2011 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Sell | S | 96.71 | 18,000 | 1,740,800 | 21,990 | 40 K to 22 K (-45.01 %) |
Apr 04 2011 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | A | 0.00 | 13,622 | 0 | 13,622 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 3,500 | 0 | 3,500 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 700 | 0 | 2,100 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 103.71 | 186 | 19,290 | 9,862 | 10 K to 9.9 K (-1.85 %) |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 700 | 0 | 10,048 | 9.3 K to 10 K (+7.49 %) |
Apr 04 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 13,950 | 0 | 13,950 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | A | 0.00 | 30,635 | 0 | 30,635 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Option Exercise | A | 0.00 | 1,469 | 0 | 1,469 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | A | 0.00 | 1,469 | 0 | 1,469 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | M | 0.00 | 700 | 0 | 2,100 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | A | 0.00 | 3,500 | 0 | 3,500 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Payment of Exercise | F | 103.71 | 186 | 19,290 | 62,733 | 62.9 K to 62.7 K (-0.30 %) |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Buy | M | 0.00 | 700 | 0 | 62,919 | 62.2 K to 62.9 K (+1.13 %) |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | A | 0.00 | 1,469 | 0 | 1,469 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Option Exercise | A | 0.00 | 1,469 | 0 | 1,469 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | Schouten Jacobus | Director | Option Exercise | A | 0.00 | 1,469 | 0 | 1,469 | |
Apr 04 2011 | CLB | CORE LABORATORIES ... | VRIESENDORP ALEXANDER | Director | Option Exercise | A | 0.00 | 1,469 | 0 | 1,469 | |
Mar 02 2011 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,200 | 0 | 4,400 | |
Mar 02 2011 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 100.29 | 601 | 60,274 | 188,857 | 189.5 K to 188.9 K (-0.32 %) |
Mar 02 2011 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 2,200 | 0 | 189,458 | 187.3 K to 189.5 K (+1.17 %) |
Mar 02 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | M | 0.00 | 400 | 0 | 800 | |
Mar 02 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Payment of Exercise | F | 100.29 | 123 | 12,336 | 62,219 | 62.3 K to 62.2 K (-0.20 %) |
Mar 02 2011 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Buy | M | 0.00 | 400 | 0 | 62,342 | 61.9 K to 62.3 K (+0.65 %) |
Mar 02 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 200 | 0 | 400 | |
Mar 02 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 100.29 | 62 | 6,218 | 9,348 | 9.4 K to 9.3 K (-0.66 %) |
Mar 02 2011 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 200 | 0 | 9,410 | 9.2 K to 9.4 K (+2.17 %) |
Mar 02 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 2,200 | 0 | 4,400 | |
Mar 02 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Payment of Exercise | F | 100.29 | 595 | 59,673 | 99,781 | 100.4 K to 99.8 K (-0.59 %) |
Mar 02 2011 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Buy | M | 0.00 | 2,200 | 0 | 100,376 | 98.2 K to 100.4 K (+2.24 %) |
Feb 16 2011 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Sell | S | 98.33 | 10,000 | 983,329 | 39,990 | 50 K to 40 K (-20.00 %) |
Dec 03 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 400 | 0 | 800 | |
Dec 03 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 86.81 | 106 | 9,202 | 9,210 | 9.3 K to 9.2 K (-1.14 %) |
Dec 03 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 400 | 0 | 9,316 | 8.9 K to 9.3 K (+4.49 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | VRIESENDORP ALEXANDER | Director | Option Exercise | M | 0.00 | 4,000 | 0 | 0 | |
Aug 23 2010 | CLB | CORE LABORATORIES ... | VRIESENDORP ALEXANDER | Director | Payment of Exercise | F | 78.34 | 2,080 | 162,947 | 5,726 | 7.8 K to 5.7 K (-26.65 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | VRIESENDORP ALEXANDER | Director | Buy | M | 0.00 | 4,000 | 0 | 7,806 | 3.8 K to 7.8 K (+105.10 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Schouten Jacobus | Director | Option Exercise | M | 0.00 | 4,000 | 0 | 0 | |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Schouten Jacobus | Director | Payment of Exercise | F | 78.34 | 2,080 | 162,947 | 3,840 | 5.9 K to 3.8 K (-35.14 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Schouten Jacobus | Director | Buy | M | 0.00 | 4,000 | 0 | 5,920 | 1.9 K to 5.9 K (+208.33 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Option Exercise | M | 0.00 | 4,000 | 0 | 0 | |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Payment of Exercise | F | 78.34 | 13 | 1,018 | 43,987 | 44 K to 44 K (-0.03 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Buy | M | 0.00 | 4,000 | 0 | 44,000 | 40 K to 44 K (+10.00 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | M | 0.00 | 4,000 | 0 | 0 | |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Payment of Exercise | F | 78.34 | 4 | 313 | 67,990 | 68 K to 68 K (-0.01 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Buy | M | 0.00 | 4,000 | 0 | 67,994 | 64 K to 68 K (+6.25 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | M | 0.00 | 4,000 | 0 | 0 | |
Aug 23 2010 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Payment of Exercise | F | 78.34 | 4 | 313 | 14,022 | 14 K to 14 K (-0.03 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Buy | M | 0.00 | 4,000 | 0 | 14,026 | 10 K to 14 K (+39.90 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Option Exercise | M | 0.00 | 4,000 | 0 | 0 | |
Aug 23 2010 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Payment of Exercise | F | 78.34 | 4 | 313 | 49,990 | 50 K to 50 K (-0.01 %) |
Aug 23 2010 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Buy | M | 0.00 | 4,000 | 0 | 49,994 | 46 K to 50 K (+8.70 %) |
Jul 30 2010 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 76.18 | 17,791 | 1,355,379 | 381,962 | 399.8 K to 382 K (-4.45 %) |
Jul 30 2010 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 75.73 | 18,950 | 1,435,078 | 399,753 | 418.7 K to 399.8 K (-4.53 %) |
Jul 30 2010 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 77.00 | 300 | 23,100 | 418,703 | 419 K to 418.7 K (-0.07 %) |
Jul 30 2010 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 76.16 | 56,147 | 4,275,993 | 419,003 | 475.2 K to 419 K (-11.82 %) |
Jul 30 2010 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Sell | S | 75.92 | 6,812 | 517,151 | 475,150 | 482 K to 475.2 K (-1.41 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Sell | D | 77.86 | 6,317 | 491,871 | 40,000 | 46.3 K to 40 K (-13.64 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Sell | S | 78.44 | 33,683 | 2,642,051 | 46,317 | 80 K to 46.3 K (-42.10 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Sell | D | 78.31 | 34,000 | 2,662,452 | 63,994 | 98 K to 64 K (-34.70 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | D | 77.37 | 37,893 | 2,931,770 | 207,258 | 245.2 K to 207.3 K (-15.46 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | D | 78.14 | 34,012 | 2,657,640 | 245,151 | 279.2 K to 245.2 K (-12.18 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | D | 77.86 | 8,657 | 674,014 | 279,163 | 287.8 K to 279.2 K (-3.01 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Sell | D | 76.44 | 26,913 | 2,057,297 | 124,176 | 151.1 K to 124.2 K (-17.81 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Sell | D | 75.98 | 938 | 71,267 | 151,089 | 152 K to 151.1 K (-0.62 %) |
Jul 28 2010 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Sell | D | 77.72 | 12,149 | 944,167 | 152,027 | 164.2 K to 152 K (-7.40 %) |
Jul 02 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 500 | 0 | 2,500 | |
Jul 02 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 147.61 | 133 | 19,632 | 4,458 | 4.6 K to 4.5 K (-2.90 %) |
Jul 02 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 500 | 0 | 4,591 | 4.1 K to 4.6 K (+12.22 %) |
May 20 2010 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Sell | S | 144.18 | 600 | 86,508 | 48,997 | 49.6 K to 49 K (-1.21 %) |
May 20 2010 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Sell | S | 143.96 | 2,400 | 345,504 | 49,597 | 52 K to 49.6 K (-4.62 %) |
May 17 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | M | 0.00 | 500 | 0 | 1,000 | |
May 17 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Payment of Exercise | F | 140.53 | 133 | 18,690 | 30,971 | 31.1 K to 31 K (-0.43 %) |
May 17 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Buy | M | 0.00 | 500 | 0 | 31,104 | 30.6 K to 31.1 K (+1.63 %) |
May 17 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,000 | 0 | 2,000 | |
May 17 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 140.53 | 265 | 37,240 | 143,910 | 144.2 K to 143.9 K (-0.18 %) |
May 17 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 1,000 | 0 | 144,175 | 143.2 K to 144.2 K (+0.70 %) |
May 17 2010 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 1,000 | 0 | 2,000 | |
May 17 2010 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Payment of Exercise | F | 140.53 | 265 | 37,240 | 82,088 | 82.4 K to 82.1 K (-0.32 %) |
May 17 2010 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Buy | M | 0.00 | 1,000 | 0 | 82,353 | 81.4 K to 82.4 K (+1.23 %) |
May 05 2010 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Sell | S | 151.62 | 600 | 90,973 | 5,013 | 5.6 K to 5 K (-10.69 %) |
May 05 2010 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Sell | S | 150.63 | 400 | 60,253 | 5,613 | 6 K to 5.6 K (-6.65 %) |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Option Exercise | A | 0.00 | 765 | 0 | 765 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | M | 0.00 | 350 | 0 | 1,400 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | A | 0.00 | 2,400 | 0 | 2,400 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Payment of Exercise | F | 133.12 | 93 | 12,380 | 30,604 | 30.7 K to 30.6 K (-0.30 %) |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Buy | M | 0.00 | 350 | 0 | 30,697 | 30.3 K to 30.7 K (+1.15 %) |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 350 | 0 | 1,400 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 2,400 | 0 | 2,400 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 133.12 | 93 | 12,380 | 4,091 | 4.2 K to 4.1 K (-2.22 %) |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 350 | 0 | 4,184 | 3.8 K to 4.2 K (+9.13 %) |
Apr 05 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | A | 0.00 | 13,800 | 0 | 13,800 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Schouten Jacobus | Director | Option Exercise | A | 0.00 | 765 | 0 | 765 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | A | 0.00 | 765 | 0 | 765 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | VRIESENDORP ALEXANDER | Director | Option Exercise | A | 0.00 | 765 | 0 | 765 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | A | 0.00 | 765 | 0 | 765 | |
Apr 05 2010 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Option Exercise | A | 0.00 | 765 | 0 | 765 | |
Mar 02 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | M | 0.00 | 200 | 0 | 600 | |
Mar 02 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Payment of Exercise | F | 124.37 | 66 | 8,208 | 30,347 | 30.4 K to 30.3 K (-0.22 %) |
Mar 02 2010 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Buy | M | 0.00 | 200 | 0 | 30,413 | 30.2 K to 30.4 K (+0.66 %) |
Mar 02 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 100 | 0 | 300 | |
Mar 02 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 124.37 | 33 | 4,104 | 3,834 | 3.9 K to 3.8 K (-0.85 %) |
Mar 02 2010 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 100 | 0 | 3,867 | 3.8 K to 3.9 K (+2.65 %) |
Mar 02 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,100 | 0 | 3,300 | |
Mar 02 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 124.37 | 315 | 39,177 | 143,175 | 143.5 K to 143.2 K (-0.22 %) |
Mar 02 2010 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 1,100 | 0 | 143,490 | 142.4 K to 143.5 K (+0.77 %) |